Ledger.Open graph →
SEC Form D · filed October 27, 2010

NAPO PHARMACEUTICALS INC

Offering
$8.9M
Sold
$3.4M
Exemption
—
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (14)

Thomas Van Dyck · San Francisco, CADirectorJack Van Hulst · San Francisco, CADirectorGregory Stock · San Francisco, CADirectorSir William Young · San Francisco, CADirectorWilliam Baquet · New York, NYExecPravin Chaturvedi · South San Francisco, CAExecKate Adams · Boston, MAExecJeffrey S. Froikin-Gordon · Washington, Washington, D.C.ExecPatrick Agemian · Grand Cayman, Cayman IslandsExecR. S. Egginton · Minneapolis, MNDirectorJohn P. Martinsen · Minneapolis, MNDirectorJohn W. Walsh · Minneapolis, MNDirectorRoger L. Cornett · Minneapolis, MNDirectorPravin Chaturvedi · Woburn, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗